Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.
about
CT-P13 in the treatment of rheumatoid arthritis.Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations.The use of glucocorticoids in early rheumatoid arthritis.Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable?
P2860
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tapering conventional syntheti ...... follow-up of the tREACH trial.
@en
Tapering conventional syntheti ...... follow-up of the tREACH trial.
@nl
type
label
Tapering conventional syntheti ...... follow-up of the tREACH trial.
@en
Tapering conventional syntheti ...... follow-up of the tREACH trial.
@nl
prefLabel
Tapering conventional syntheti ...... follow-up of the tREACH trial.
@en
Tapering conventional syntheti ...... follow-up of the tREACH trial.
@nl
P2093
P2860
P1476
Tapering conventional syntheti ...... follow-up of the tREACH trial.
@en
P2093
A E A M Weel
A H Gerards
B A Grillet
D van Zeben
I Tchetverikov
J M W Hazes
M V van Krugten
P B J de Sonnaville
P H P de Jong
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-209272
P407
P577
2016-06-09T00:00:00Z